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a b s t r a c t
The formation of vascular structures requires precisely controlled proliferation of endothelial cells (ECs),
which occurs through strict regulation of the cell cycle. However, the mechanism by which EC
proliferation is coordinated during vascular formation remains largely unknown, since a method of
analyzing cell-cycle progression of ECs in living animals has been lacking. Thus, we devised a novel
system allowing the cell-cycle progression of ECs to be visualized in vivo. To achieve this aim, we
generated a transgenic zebraﬁsh line that expresses zFucci (zebraﬁsh ﬂuorescent ubiquitination-based
cell cycle indicator) speciﬁcally in ECs (an EC-zFucci Tg line). We ﬁrst assessed whether this system
works by labeling the S phase ECs with EdU, then performing time-lapse imaging analyses and, ﬁnally,
examining the effects of cell-cycle inhibitors. Employing the EC-zFucci Tg line, we analyzed the cell-cycle
progression of ECs during vascular development in different regions and at different time points and
found that ECs proliferate actively in the developing vasculature. The proliferation of ECs also contributes
to the elongation of newly formed blood vessels. While ECs divide during elongation in intersegmental
vessels, ECs proliferate in the primordial hindbrain channel to serve as an EC reservoir and migrate into
basilar and central arteries, thereby contributing to new blood vessel formation. Furthermore, while EC
proliferation is not essential for the formation of the basic framework structures of intersegmental and
caudal vessels, it appears to be required for full maturation of these vessels. In addition, venous ECs
mainly proliferate in the late stage of vascular development, whereas arterial ECs become quiescent at
this stage. Thus, we anticipate that the EC-zFucci Tg line can serve as a tool for detailed studies of the
proliferation of ECs in various forms of vascular development in vivo.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The vasculature is the earliest organ to form in the developing
vertebrate embryo. The formation of blood vessels occurs through
two fundamentally distinct processes, vasculogenesis and angio-
genesis (Carmeliet, 2000; Risau, 1997; Risau and Flamme, 1995).
Vasculogenesis constitutes the de novo formation of a primitive
vascular network through the differentiation of mesodermal cells
into vascular precursor cells (angioblasts) and their subsequent
proliferation, coalescence, and remodeling. On the other hand,
angiogenesis is the process of new blood vessel formation which
involves sprouting of ECs (ECs) from preexisting vessels, followed
by their proliferation and migration. Precise control of the pro-
liferation of ECs is essential for both vasculogenesis and angiogen-
esis (Ausprunk and Folkman, 1977; Herbert and Stainier, 2011).
Although several studies have investigated the mechanisms gov-
erning EC proliferation, the dynamics of this proliferation during
vascular development in vivo remain poorly understood.
Cell proliferation is strictly regulated by the cell cycle, which is
divided into four phases: G1 (ﬁrst gap), S (DNA synthesis), G2
(second gap), and M (mitosis). The cell-cycle control of ECs has long
been studied using in vitro models in which cultured ECs are plated
on plastic dishes (Akimoto et al., 2000; Favot et al., 2004; Kimura et
al., 2000; Zhou et al., 2012). However, little is known about how the
cell cycle of ECs is coordinated during vascular development, since a
method allowing the cell-cycle progression of ECs to be analyzed in
living animals has not been available. To date, 5-bromo-20-deox-
yuridine (BrdU) or 5-ethynyl-20-deoxyuridine (EdU) labeling has
been utilized to detect S phase cells in tissue samples (Yu et al.,
1992). Besides BrdU or EdU labeling, cell proliferation in tissue
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samples can also be assessed by immunohistochemistry with
antibodies against cell-cycle and proliferation markers such as
proliferating cell nuclear antigen, phosphohistone-H3 and Ki-67
(Cattoretti et al., 1992; Hendzel et al., 1997; Yu et al., 1992).
However, these techniques do not allow assessment of cell-cycle
progression and cell proliferation in living animals. To overcome
this problem, Tg zebraﬁsh lines with ECs expressing ﬂuorescent
proteins tagged with a nuclear localization signal (NLS) were
established (Roman et al., 2002). Although these Tg lines enable
ECs undergoing mitosis to be observed, they cannot be used to
analyze the cell-cycle progression dynamics of ECs.
Cell-cycle progression is mediated by the levels of cell-cycle
regulators, which are strictly controlled by the ubiquitination-
dependent protein degradation pathway throughout the cell cycle
(Ang and Harper, 2004; Nakayama and Nakayama, 2006). By
harnessing the regulation of cell-cycle dependent ubiquitination,
we developed a genetically encoded biosensor for cell-cycle
progression: Fucci (ﬂuorescent ubiquitination-based cell cycle
indicator) (Sakaue-Sawano et al., 2008). Fucci is a set of ﬂuorescent
probes, which are generated by fusing red and green ﬂuorescent
proteins to the ubiquitination domains of human Cdt1 and human
geminin, respectively. In the cells expressing these probes, the
nuclei of G0/G1 phase cells and those of S/G2/M phase cells can be
identiﬁed by red and green ﬂuorescence, respectively. In addition,
we also generated a Fucci derivative (zFucci) allowing visualization
of cell-cycle progression in zebraﬁsh (Sugiyama et al., 2009). Since
zebraﬁsh embryos are transparent, transgenic ﬁsh embryos
expressing zFucci probes provide a powerful tool for visualizing
cell-cycle dynamics in living animals.
In the present study, we succeeded in developing an EC-speciﬁc
zFucci transgenic (EC-zFucci Tg) line, thereby allowing the cell-
cycle dynamics of ECs to be visualized in vivo. Exploiting this line,
we visualized the cell-cycle progression of ECs during the devel-
opment of several types of vascular structures including interseg-
mental vessels (ISVs), caudal vessels, and hindbrain vessels. We
also studied the late stage of vascular development. Our analyses
clearly show the advantages of using the EC-zFucci Tg line for
studying EC proliferation in vivo.
Materials and methods
Plasmid construction
The Tol2 vector system was kindly provided by K. Kawakami
(National Institute of Genetics, Japan) (Kawakami et al., 2004;
Urasaki et al., 2006). The pTolﬂi1 vector was constructed by
removing a cDNA fragment containing green ﬂuorescence protein
(GFP) and Gateway cassette from the pTolﬂi1epEGFPDest plasmid,
a gift from N. Lawson (University of Massachusetts Medical School)
(Lawson and Weinstein, 2002). To generate the pTolﬂk1 plasmid,
the ﬂi1 enhancer/promoter was removed from the pTolﬂi1 vector,
and replaced with the ﬂk1 promoter, a gift from D.Y. Stainier (The
University of California, San Francisco) (Jin et al., 2005b).
The S/G2/M marker for ﬁsh cells was generated by fusing
monomeric (m)Venus to the N-terminal 100 aa of zebraﬁsh
geminin (mV-zGem), while the G0/G1 marker was composed of
mCherry and the N-terminal 190 aa of zebraﬁsh Cdt1 (mC-zCdt)
(Sugiyama et al., 2009). To construct the pTolﬂk1-mVenus-zGem
(1/100) and pTol1ﬂk1-mCherry-zCdt1 (1/190), cDNA fragments
encoding mV-zGem and mC-zCdt were subcloned into the pTolﬂk1
vector, respectively, as shown in Fig. 1A. An oligonucleotide
encoding NLS derived from SV40 (PKKKRKV) was inserted into
the EcoRI/XhoI sites of a pcDNA3-td-EosFP vector (Molecular
Biotechnology) to generate the plasmid encoding NLS-tagged
tandem dimer Eos ﬂuorescence protein (NLS-Eos). To construct
the pTolﬂk1-NLS-Eos vector, NLS-Eos cDNAwas subcloned into the
pTolﬂk1 vector. Similarly, a cDNA expressing NLS-tagged mCherry
was subcloned into the pTolﬂk1 vector to yield pTolﬂk1-NLS-
mCherry. An oligonucleotide encoding the myristoylation (Myr)
signal derived from Lyn kinase was subcloned into pEGFP-N1 and
pmCherry-N1 vectors (Clontech, Takara Bio Inc.) to construct the
plasmid encoding Myr signal-tagged GFP (Myr-GFP) and that
encoding Myr signal-tagged mCherry (Myr-mCherry), respectively.
The pTolﬂi1-Myr-GFP and pTolﬂi1-Myr-mCherry were constructed
by inserting Myr-GFP and Myr-mCherry cDNA into the pTolﬂi1
vector, respectively. Details can be provided upon request.
Zebraﬁsh husbandry
Zebraﬁsh were maintained and bred under standard condi-
tions. Embryos were staged by hours post-fertilization (hpf) at
28 1C (Kimmel et al., 1995). Animal experiments were approved by
the animal committee of the National Cerebral and Cardiovascular
Center and performed according to the regulations of the National
Cerebral and Cardiovascular Center.
Generation of transgenic zebraﬁsh lines
Tol2 transposase mRNA was in vitro transcribed with SP6 RNA
polymerase, using NotI-linearized pCS-TP vector as a template,
employing the mMESSAGE mMACHINE kit (Ambion) (Kawakami
et al., 2004; Urasaki et al., 2006). To generate the Tg(ﬂk1:mV-Gem),
Tg(ﬂk1:mC-Cdt), Tg(ﬂk1:NLS-mCherry(mC)), Tg(ﬂk1:NLS-Eos), Tg(ﬂi1:
Myr-GFP) and Tg(ﬂi1:Myr-mCherry(mC)) ﬁsh lines, the Tol2 plasmids
constructed as described above were microinjected along with Tol2
transposase RNA into one-cell stage embryos to generate transgenic
lines. Embryos showing transient expression of ﬂuorescence pro-
teins in the vasculature were selected, raised to adulthood, and
became founders in which germline transmission was conﬁrmed.
in vivo imaging
Embryos were dechorionated and anesthetized in 0.016% tri-
caine (Sigma-Aldrich) in E3 embryo medium (5 mM NaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mM MgSO4). The embryos were mounted
in 1% low-melting agarose dissolved in E3 medium poured on a 35-
mm-in-diameter glass-base dish (Asahi Techno Glass), and sub-
merged in E3 medium supplemented with 0.016% tricaine and
0.2 mM phenylthiourea. Confocal images were taken with an
FV1000 (Olympus) confocal upright microscope system equipped
with water-immersion 10 (LUMPlanFL, NA 0.30), 20 (XLUM-
PlanFL, NA 1.0) and 40 (LUMPlanFL, NA 0.80) lenses. The 473 nm
and 559 nm laser lines were employed for green-yellow ﬂuorescent
proteins (mVenus and Eos) and red ﬂuorescent proteins (mCherry
and photoconverted Eos), respectively. For confocal time-lapse
imaging, images were collected every 10–15 min for 5–10 h. To
avoid cross-detection of green and red signals, images were
acquired sequentially at 473 nm and 559 nm. Image ﬁles were
processed and analyzed using Volocity software (Improvision).
Whole-mount immunohistochemistry and EdU labeling
For whole-mount immunohistochemistry, embryos were ﬁxed
in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS)
at 4 1C overnight, washed with PBS, dehydrated in 100% MeOH at
20 1C overnight, and rehydrated by serial incubations with PBS
and MeOH (75% MeOH/25% PBS for 5 min, 50% MeOH/50% PBS for
5 min, 25% MeOH/75% PBS for 5 min, 100% PBS for 5 min). The
embryos were then permeabilized in PBS containing 0.1% Tween
20 and 0.1% Triton X-100 (PBSTX) four times for 5 min, and
blocked with PBSTX containing 1% bovine serum albumin and
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Fig. 1. Development and characterization of transgenic zebraﬁsh lines expressing zFucci cell-cycle biosensors in endothelial cells (ECs). (A) Schematic representation of the
plasmids used for delivering transgenes expressing mVenus-zGem (1/100) (mV-zGem) and mCherry-zCdt1(1/190) (mC-zCdt) under control of the ﬂk1 promoter. (B) Upper,
ﬂuorescence image (mV-zGem [green] and mC-zCdt1 [red]) of an EC-zFucci, Tg(ﬂk1:mV-zGem);(ﬂk1:mC-Cdt) embryo, at 31 hpf; lower, bright ﬁeld images. (C) 3D-rendered
confocal stack ﬂuorescence images of the caudal regions of the Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryo at 33 hpf. Upper, mVenus image; lower, the merged image of mVenus
(green) and mCherry (red). All of the confocal ﬂuorescence images are lateral views and displayed as anterior to the left, unless otherwise described, in the following images.
(D) 3D-rendered confocal images of the caudal regions of the Tg(ﬂk1:mC-Cdt);(ﬂi1:Myr-GFP) embryo at 48 hpf. Upper, mCherry image; lower, the merged image of mVenus
(green) and mCherry (red). (E) Images of the EC-zFucci embryo at 29.5 hpf treated with EdU for 1 h. mVenus images (green), mCherry images (red) and EdU images
visualized by Alexa 647-azide (blue) of the trunk vessel are shown as indicated at the lower left corner of the image. Yellow, pink and white arrowheads indicate mV-zGem/
EdU double-positive cells, mV-zGem-positive/EdU-negative cells and mC-zCdt-positive/EdU-negative cells, respectively. (F) Percentages of mV-zGem-positive, mC-zCdt-positive
and mV-zGem/mC-zCdt double positive cells labeled without () or with (þ) EdU as observed in E were quantiﬁed (n¼55). Scale bars, 200 μm (B) and 100 μm (C–E).
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Fig. 2. Validation of the EC-zFucci Tg ﬁsh line. (A) Confocal 3D ﬂuorescence image of the intersegmental vessel (ISV) of an EC-zFucci embryo at 36 hpf (ﬁrst column) and the
corresponding subsequent time-lapse images (from second to sixth columns) at the elapsed time (h:min) indicated at the bottom. Top, mVenus images; middle, mCherry
images; bottom, the merged images. Note that an mV-zGem-positive cell (arrows at 0:00 and 0:20) divides into two daughter cells (arrows at 0:50), which subsequently lose
mVenus ﬂuorescence and start to emit mCherry ﬂuorescence (arrows at 3:10, 3:50 and 8:10). (B) Confocal 3D ﬂuorescence image of the ISV of an EC-zFucci embryo at 38 hpf
(ﬁrst column) and the corresponding subsequent time-lapse images (from second to seventh columns) at the elapsed time (h:min) indicated at the bottom are shown,
essentially as in A. Note that the mC-zCdt-positive cell (arrows at 0:00 and 1:00) loses mCherry ﬂuorescence (arrow at 1:10), starts to emit mVenus ﬂuorescence (arrows at
2:30, 5:00 and 6:00), and subsequently divides into two daughter cells (arrows at 6:20 and 7:00). (C) 3D-rendered confocal images of the caudal regions of 48 hpf Tg(ﬂk1:mV-
zGem);(ﬂi1:Myr-mC) embryos treated with either DMSO or both hydroxyurea and aphidicolin (HU/APH) from 30 to 48 hpf. Upper, mVenus images; lower, the merged images
of mVenus and mCherry. Scale bars, 100 μm. (D) Duration: time that mVenus-positive cells in the EC-zFucci Tg embryos at 36 hpf continue to emit mVenus ﬂuorescence. Tg
(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos were treated from 30 hpf with either DMSO (closed circles) or HU/APH (open circles), and time-lapse imaged starting at 36 hpf for 9 h
20 min to track the mVenus-positive cells. The y-axis indicates the number of mVenus-positive cells, while the x-axis shows the time after starting the time-lapse imaging.
Data are expressed as percentages relative to that observed at the beginning of the imaging (DMSO [n¼35], HU/APH [n¼41]).
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0.1% normal goat serum for 2 h at room temperature (RT). Then,
the embryos were stained with anti-GFP mouse monoclonal anti-
body (Clontech, Takara Bio Inc.) and anti-DsRed rabbit polyclonal
antibody (Clontech, Takara Bio Inc.) at 4 1C overnight to detect
mVenus and mCherry, respectively. Proteins reacting with the
primary antibody were visualized with species-matched Alexa
S. Fukuhara et al. / Developmental Biology 393 (2014) 10–2314
488- and Alexa 546-labeled secondary antibodies (Molecular
Probes, Invitrogen).
EdU labeling was performed using the Click-iT EdU Alexa Flour
imaging kit (Molecular Probes, Invitrogen) basically according to
the manufacturer's instructions. Tg(ﬂk1:mV-zGem);Tg(ﬂk1:mC-
zCdt) ﬁsh embryos were dechorionated at 28.5 hpf, and incubated
with 400 μM EdU for 1 h at 28 1C. After ﬁxation and permeabiliza-
tion, the embryos were rinsed with ddH2O, then incubated with
Alexa 647-azaide for 30 min at RT, and ﬁnally subjected to whole-
mount immunohistochemistry as described above.
Fluorescence images of Alexa 488, Alexa 546 and Alexa 647 were
recorded with an FV1000 confocal upright microscope system
equipped with 473 nm, 559 nm and 633 nm laser lines, respectively.
Morpholino oligonucleotide (MO) injections
For morpholino oligonucleotide (MO)-mediated gene knock-
down, embryos were injected at the one-cell or two-cell stage
with control MO (Gene Tools), 5 ng of delta-like 4 (dll4) MO, and
5 ng of ckdn1b cyclin-dependent kinase inhibitor 1B (cdkn1b) MO
(Gene Tools). The sequences for the already-validated MOs used in
this study are dll4 MO, 50-TAGGGTTTAGTCTTACCTTGGTCAC-30
(Siekmann and Lawson, 2007); ckdn1b MO, 50-ACGGTCAAAATT-
CAAAGCACATACC-30 (Nicoli et al., 2012).
Photoconversion
Tg(ﬂk1:NLS-Eos) ﬁsh embryos were dechorionated at the stage
indicated in the ﬁgure legend, and mounted as described above.
The NLS-Eos-positive ECs at the growing edges of caudal vessels
were photolabelled by photoconverting the ﬂuorescence of NLS-
Eos from green to red. For photoconversion, a 405 nm laser was
focused onto an area of interest for 60 s2 with 100% power,
10 μs/pixel (tornado function). The embryos were then subjected
to time-lapse imaging as described above.
Chemical treatment
To block the cell cycle, embryos were treated with 150 μM
aphidicolin (APH) and 20 mM hydroxyurea (HU) in the E3 embryo
medium containing 4% dimethyl sulfoxide (DMSO) as described
previously (Zhang et al., 2008).
Statistical analysis
Data were analyzed using GraphPad Prism software (GraphPad
Software Inc.). Statistical signiﬁcance was determined using a two-
tailed Mann–Whitney U test for paired samples or one-way
analysis of variance and nonparametric tests for multiple groups.
P-valueso0.05 were considered statistically signiﬁcant.
Results
Development of a transgenic zebraﬁsh line expressing cell-cycle
biosensor zFucci speciﬁcally in ECs
To visualize the cell-cycle progression of ECs in living animals,
we developed a transgenic zebraﬁsh line that expresses either a
S/G2/M marker, mVenus-zGeminin(1/100) (mV-zGem), or a G0/G1
marker, mCherry-zCdt1(1/190) (mC-zCdt), under ﬂk1 promoter
control (Fig. 1A). We crossbred these ﬁsh to generate a double Tg
zebraﬁsh line, Tg(ﬂk1:mV-zGem);(ﬂk1:mC-zCdt), which we call EC-
speciﬁc zFucci (EC-zFucci) Tg ﬁsh (Fig. 1B). To conﬁrm EC-speciﬁc
expressions of mV-zGem and mC-zCdt in the EC-zFucci ﬁsh, we
analyzed two double Tg embryos, Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC)
and Tg(ﬂk1:mC-zCdt);(ﬂi1:Myr-GFP). In the Tg(ﬂk1:mV-zGem);(ﬂi1:
Myr-mC) ﬁsh embryo, mV-zGem expression was conﬁned to
mCherry ﬂuorescence-marked ECs (Fig. 1C). Similarly, mCherry
ﬂuorescence was detected in the nuclei of GFP ﬂuorescence-
marked ECs in the Tg(ﬂk1:mC-zCdt);(ﬂi1:Myr-GFP) ﬁsh embryo
(Fig. 1D). These ﬁndings indicate that the EC-zFucci ﬁsh line
exhibits EC-speciﬁc expressions of mV-zGem and mC-zCdt. How-
ever, the ﬂuorescence signals of mV-zGem and mC-zCdt were only
weakly detected in the axial vessels of the EC-zFucci ﬁsh embryo
before 24 hpf. Therefore, the EC-zFucci reporter line may not be
suitable for analyzing the cell-cycle dynamics of ECs during the
early stage of vascular development.
Next, we conﬁrmed that mVenus and mCherry ﬂuorescence in
the EC-zFucci embryos actually mark ECs in the S/G2/M and G1
phases of the cell cycle, respectively. First, we pulse-labeled an EC-
zFucci ﬁsh with EdU at 29.5 hpf for 1 h to identify S-phase cells. In
the trunk regions, most of the mVenus-positive cells were labeled
with EdU, whereas none of the mCherry-positive cells showed EdU
incorporation, indicating that ECs in the S phase are marked
selectively by mVenus ﬂuorescence in the EC-zFucci embryos
(Fig. 1E, F). In addition, we tracked either mCherry or mVenus
ﬂuorescence-positive ECs in the EC-zFucci embryo by performing
time-lapse imaging. We observed the mVenus-positive EC to
divide into two daughter cells, which subsequently lost mVenus
ﬂuorescence and started to exhibit mCherry ﬂuorescence (Fig. 2A).
Furthermore, the mCherry-positive EC exhibited mVenus ﬂuores-
cence immediately after losing the red ﬂuorescence, and then
underwent cytokinesis (Fig. 2B). Time-lapse imaging analyses
showed mVenus ﬂuorescence at 278776 min (n¼6) and
69744 min (n¼27) before and after cell division, respectively.
However, most of the mCherry-positive cells continued to exhibit
mCherry ﬂuorescence in the EC-zFucci embryos. Since mC-zCdt
marks the cells not only in the G1 phase but also in the G0 phase
of the cell cycle, these ﬁndings suggest that most of the mCherry-
positive ECs had left the cell cycle. We further examined the effects
of HU and APH, DNA replication inhibitors that induce S phase
arrest (Carr, 2002; Ikegami et al., 1978), on the expression of mV-
Fig. 3. Cell-cycle progression of ECs during ISV formation. (A, B) Time-lapse confocal imaging of ISV sprouting from the dorsal aorta (DA) in the trunk region of a Tg(ﬂk1:mV-
zGem);(ﬂk1:NLS-mC) ﬁsh embryo. (A) ISVs used for imaging analyses. An ISV of the boxed region is presented schematically. (B) 3D-rendered confocal 3D image of the
embryo at 24.5 hpf (left upper) and its subsequent time-lapse images at the elapsed time (hr:min) indicated at the bottom (mVenus [green] and mCherry [red]). Note that an
EC in the S/G2/M phase sprouts from the DA (arrows in 0:00 and 1:50), divides during dorsal migration (arrows in 3:10, 3:50, 4:20), leaves the M-phase (arrows in 5:10 and
6:40), and further migrates dorsally (arrow in 9:00) to form an ISV. (C) Percentages of mV-zGem-negative () and mV-zGem-positive (þ) ECs involved only in forming ISV
by sprouting from the DA. Data are shown as means7s.d. (n¼5). (D) Types of ECs that divide during ISV formation. Cell division was deﬁned by the division of mV-zGem-
positive ECs. The numbers of ISVs showing tip cell division (Tip), stalk cell division (Stalk) or division of both tip and stalk cells (Tip/Stalk) or showing no cell division (None)
were divided by the total number of ISVs observed (n¼34). (E) Quantiﬁcation of the number of EC divisions during ISV formation. The numbers of ISVs showing no cell
division, one, two, or three rounds of cell division divided by the total numbers of ISVs observed (n¼34). (F) A model of cell-cycle regulation of ECs during ISV formation.
(G) 3D-rendered confocal 3D images of the trunk regions of Tg(ﬂk1:mV-zGem);(ﬂk1:NLS-mC) embryos injected with control MO (upper panel) or dll4 MO (lower panel) at
48 hpf. Upper, merged images (mVenus [green] and mCherry [red]) of control morphants; lower, those of dll4 morphants. (H, I) The number of mV-zGem-positive cells
(H) and the total number of ECs (I) within the ﬁve ISVs. Data are shown as means7s.d. (n¼11). (J) 3D-rendered confocal images of the trunk regions of 32 hpf Tg(ﬂi1:Myr-
mC);( ﬂk1:NLS-Eos) embryos treated from 20 hpf with DMSO (left column) or HU/APH (right column). Upper, Eos images; lower, the merged images of Eos and mCherry. Scale
bars, 100 μm. (K) The numbers of ECs in the posterior cardinal vein (PCV), DA and ISV/dorsal longitudinal anastomotic vessel (DLAV) within the ﬁve ISVs as observed in J were
counted, and shown as means7s.d. (DMSO [n¼9], HU/APH [n¼11]). ISV, intersegmental vessel; DA, dorsal aorta; DLAV, dorsal longitudinal anastomotic vessels. nnpo0.01,
nnnpo0.001 (C, H, I, K). n.s., no signiﬁcance.
S. Fukuhara et al. / Developmental Biology 393 (2014) 10–23 15
zGem in ECs (Fig. 2C, D). In the Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC)
embryos treated with HU and APH (HU/APH), mVenus ﬂuores-
cence in ECs persisted for at least 10 h after starting the observa-
tion, whereas most of the mVenus-positive ECs had lost
ﬂuorescence by 6 h in the DMSO-treated embryos (Fig. 2D).
Accordingly, the HU/APH-treated embryos exhibited increased
numbers of mVenus-positive ECs (Fig. 2C), although the total
number of ECs was decreased by HU/APH treatment, as described
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below. Collectively, these results indicate that the EC-zFucci ﬁsh
line allows us to precisely visualize the cell-cycle progression of
ECs in living animals.
Cell-cycle progression of ECs during intersegmental vessel formation
The development of ISVs in the zebraﬁsh provides an excellent
model system for the study of sprouting angiogenesis in vivo (Blum
et al., 2008; Isogai et al., 2003; Lawson and Weinstein, 2002).
During ISV formation, ECs sprout from the dorsal aorta (DA) and
migrate along the somite boundary toward the dorsolateral roof of
the neural tube. The EC located at the leading edge of each sprout is
called the tip cell, and is followed by a few stalk cells. To investigate
cell-cycle control in sprouting angiogenesis, we observed S/G2/M
phase ECs during ISV formation by performing time-lapse imaging
of Tg(ﬂk1:mV-zGem);(ﬂk1:NLS-mC) embryos in which NLS-tagged
mCherry was expressed in the nuclei of ECs (Fig. 3A, B and
Supplemental Movie 1). Approximately 80% of ECs that sprouted
from the DA were found in the S/G2/M phase of the cell cycle
(Fig. 3B, C). After sprouting from the DA, the cells in the S/G2/M
phase became tip cells, migrated dorsally, and underwent cell
division between horizontal myosepta, giving rise to both tip and
stalk cells which immediately left the M-phase (Fig. 3B). The tip cell
further migrated dorsally to form an ISV. Careful analysis of the
time-lapse imaging results revealed that about 60% of tip cells
divided during ISV formation (Fig. 3D). In addition, only one round
of cell division occurred to form one ISV in approximately 70% of
cases (Fig. 3E). These results show that ECs progressing through the
cell cycle sprout from the DA, then undergo one round of cell
division during dorsal migration and form ISVs (Fig. 3F).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.06.015.
Delta-like 4 (Dll4)/Notch signal is known to regulate angiogen-
esis by restricting the angiogenic behavior of ECs (Bentley et al.,
2008; Hellstrom et al., 2007; Leslie et al., 2007; Lobov et al., 2007;
Siekmann and Lawson, 2007; Suchting et al., 2007). Indeed,
impaired Dll4/Notch signaling in zebraﬁsh results in hyper-
branching of ISVs and an increased number of ECs in these ISVs
(Leslie et al., 2007; Siekmann and Lawson, 2007). Thus, to further
evaluate the applicability of the EC-zFucci ﬁsh line, we examined
the effect of inhibiting Dll4/Notch signaling on the cell-cycle state
of ECs by injecting a MO targeting dll4 into Tg(ﬂk1:mV-zGem);(ﬂk1:
NLS-mC) embryos. The number of S/G2/M phase ECs in ISVs was
signiﬁcantly increased by knocking down dll4 (Fig. 3G,H).
Although the total number of ECs in these ISVs was also increased
in dll4 morphants, the proportion of S/G2/M phase ECs to the total
number of ECs was higher in Dll4-depleted embryos than in
control embryos (control embryos, 161%; dll4 morphants, 226%)
(Fig. 3H,I). These ﬁndings indicate that Dll4/Notch signaling
regulates angiogenesis by restricting the cell-cycle progression of
ECs. In addition, it has been shown that cyclin dependent kinase
inhibitor 1b (Cdkn1b) suppresses angiogenesis by blocking the
cell-cycle progression of ECs (Nicoli et al., 2012). Consistently, the
depletion of cdkn1b signiﬁcantly increased the number of S/G2/M
phase ECs in ISVs (Supplemental Fig. S1). Thus, our ﬁndings
further support the usefulness of the EC-zFucci ﬁsh line for
studying EC proliferation in vivo.
Role of EC proliferation in ISV formation
The presence of proliferating ECs in ISVs suggests EC prolifera-
tion to be required for ISV formation. To address this hypothesis,
we investigated the effect of inhibiting EC proliferation on the
formation of ISVs. The Tg(ﬂi1:Myr-mC);(ﬂk1:NLS-Eos) embryos, in
which the nuclei of the ECs had been labeled with Eos ﬂuores-
cence, were treated with HU/APH from 20 hpf and analyzed at
32 hpf. Unexpectedly, basic framework structures of trunk vessels,
consisting of ISVs, dorsal longitudinal anastomotic vessels (DLAVs),
the DA and the posterior cardinal vein (PCV), formed in the
embryos treated with HU/APH (Fig. 3J). Consistently, time-lapse
imaging analysis of HU/APH-treated Tg(ﬂi1:Myr-mC);(ﬂk1:NLS-Eos)
embryos revealed that the ECs sprouted from the DA, migrated
dorsally and formed ISVs even in the presence of HU/APH
(Supplemental Movie 2). These results indicate that migration of
ECs from the DA can compensate for a lack of EC proliferation
during ISV development. However, the numbers of ECs in these
ISVs, DLAVs and the DA, but not in the PCV, were signiﬁcantly
decreased by HU/APH treatment (Fig. 3K). Therefore, EC prolifera-
tion appears to be indispensable for the formation of functionally
mature ISVs.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.06.015.
Cell-cycle progression of ECs during caudal vessel formation
In zebraﬁsh, the body axis continues to extend after gastrula-
tion as a tail forms at the posterior end of the embryo (Kanki and
Ho, 1997). Concomitantly, the axial vessels elongate posteriorly,
giving rise to caudal vessels (Isogai et al., 2001) (Fig. 4A). However,
the mechanism underlying caudal vessel formation remains lar-
gely unknown. To explore this question, we investigated the cell-
cycle state of ECs during caudal vessel formation. In the zebraﬁsh
embryo at 24 hpf, vascular cord structures formed at the posterior
end of the axial vessels and contained many S/G2/M phase ECs
(Fig. 4A). At 30 and 36 hpf, the ECs in the S/G2/M phase were
mainly present in the vascular cord, caudal artery (CA) and ISVs at
the growing edge of the caudal vessels (Fig. 4A). At 48 hpf, the ECs
progressing through the cell cycle were observed to become
localized mainly in the ISVs and caudal vein plexus (CVP) of the
caudal vessels (Fig. 4A). These results suggest that EC proliferation
may contribute to the outgrowth of caudal vessels.
To assess this possibility, we performed a time-lapse imaging
study of Tg(ﬂk1:mV-zGem);(ﬂk1:NLS-mC) embryos during caudal
vessel formation. At 25–29 hpf, ECs in the S/G2/M phase were
located at the vascular cords, as shown in Fig. 4A, and proliferated
actively (Fig. 4B and Supplemental Movie 3). Interestingly, however,
NLS-mCherry-positive cells emerged just posterior to the growing
edges of caudal vessels and coalesced with the preexisting vascular
Fig. 4. Cell-cycle progression of ECs during caudal vessel formation. (A) 3D-rendered confocal images of the caudal vessels of Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos at 24,
30, 36 and 48 hpf as indicated in the ﬁrst column from the left. Bright ﬁeld images (left) and ﬂuorescence images (as indicated at the top). The boxed areas of the second and
the third columns are enlarged in the fourth and ﬁfth columns, respectively. CA, caudal vessel; VC, vascular cord; ISV, intersegmental vessel; CVP, caudal vein plexus; DLAV,
dorsal longitudinal anastomotic vessels. Scale bars, 100 μm. (B) Time-lapse confocal imaging of caudal vessel formation in the early stage (from 25 to 29 hpf) in the Tg(ﬂk1:
mV-zGem);(ﬂk1:NLS-mC) embryos. The confocal 3D image of the embryo at 25 hpf (top) and subsequent time-lapse images (from second to fourth rows) as indicated by the
elapsed time (hr:min) at the top right. Left, merged (mVenus and mCherry); center, enlarged mVenus images of the boxed region of the left panel; right, enlarged merged
image of the boxed region of the left panel. The cell movement of the posterior-most cell at the beginning (crosses) and at the end (circles) during time-lapse imaging, as
analyzed employing a cell tracking application. (C) Tg(ﬂk1:mV-zGem);(ﬂk1:NLS-mC) embryos in the late stage (from 33–37 hpf) were similarly time-lapse imaged and
analyzed as in B. Note that NLS-mCherry-positive cells merge just posterior to the growing edges of caudal vessels in the early stage, but not in the late stage, of caudal vessel
formation. (D) Time-lapse confocal imaging of caudal vessel formation at the early stage (from 23 to 27 hpf) in the Tg(ﬂk1:NLS-Eos) embryos. Confocal 3D images (at 23 hpf)
and subsequent time-lapse images of photoconverted NLS-Eos (red)-marked ECs (encircled) from original NLS-Eos (green)-marked cells by laser irradiation at 23 hpf.
Elapsed time (hr:min). Upper, merged images of Eos (green) and photoconverted Eos (red); lower, photoconverted Eos (red) images. Arrowheads indicate the anteriormost
and posteriormost of the photoconverted cells. (E) Tg(ﬂk1:NLS-Eos) embryos in the late stage (from 33 to 40 hpf) were time-lapse imaged and analyzed as in D.
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cords (Fig. 4B and Supplemental Movie 3). In clear contrast, we
detected no emergence of NLS-mCherry-positive cells in the caudal
region at 33–36 hpf (Fig. 4C and Supplemental Movie 4). Instead,
the ECs in the S/G2/M phase at the growing edges of caudal vessels
proliferated actively and migrated posteriorly (Fig. 4C and Supple-
mental Movie 4). These results suggest that development and
proliferation of angioblasts, namely vasculogenesis, both occur in
the early stage of caudal vessel formation, while the ECs located at
the growing edge proliferate and migrate in the late stage.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.06.015.
To further conﬁrm that vasculogenesis occurs during caudal
vessel formation, we performed a time-lapse imaging study of Tg
(ﬂk1:NLS-Eos) embryos in which a photoconvertible ﬂuorescence
protein (NLS-Eos) was expressed in the nuclei of ECs. We photo-
converted NLS-Eos-expressing ECs in the growing edges of caudal
vessels at 23 hpf, and conducted time-lapse imaging for 4 h. Green
ﬂuorescence-positive cells appeared in the region just posterior to
the photoconverted red ﬂuorescence-marked cells (Fig. 4D and
Supplemental Movie 5). We also marked the ECs in the posterior
ends of caudal vessels at 33 hpf by photoconverting the NLS-Eos
proteins. In clear contrast to embryos in the earlier stage, we
detected no emergence of green ﬂuorescence-positive cells.
Instead, photoconverted red ﬂuorescence-marked ECs migrated
posteriorly, thereby leading to extension of caudal vessels (Fig. 4E
and Supplemental Movie 6). Collectively, these ﬁndings indicate
that caudal vessel development depends on the early stage on
vasculogenesis that involves differentiation and proliferation of
angioblasts, while proliferation and migration of ECs contribute to
the posterior elongation of caudal vessels in the late stage.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.06.015.
Role of EC proliferation in caudal vessel formation
To investigate the requirement of EC proliferation for caudal
vessel formation, we treated the 24 hpf Tg(ﬂi1:Myr-mC);(ﬂk1:NLS-
Eos) embryos with either DMSO or HU/APH for 24 h, and analyzed
their caudal vessel structures at 48 hpf. In the caudal regions of
DMSO-treated embryos, the CA formed at the midline, while the
caudal vein (CV) and CVP were established at the ventral side of
the CA (Fig. 5A). The ISVs and DLAVs also formed at the dorsal side.
As in the DMSO-treated embryos, basic framework structures of
caudal vessels developed in the HU/APH-treated embryos (Fig. 5A).
Indeed, the axial vessels comprising the CA, CV and CVP had
vascular lumens regardless of whether the embryos had been
Fig. 5. Effect of inhibiting EC proliferation on caudal vessel formation. (A) 3D-rendered confocal images of the caudal regions of 48 hpf Tg(ﬂi1:Myr-mC);( ﬂk1:NLS-Eos)
embryos treated from 24 hpf with DMSO (upper) or HU/APH (lower). Left column, Eos images; from the second to ﬁfth columns, the merged images of Eos (green) and
mCherry (red). The boxed areas in the second column and the corresponding single scan confocal images are enlarged in the third and fourth columns, respectively. The
cross-sectional single plane images of the areas indicated by dotted lines on the fourth column are also shown in the ﬁfth column. ISV, intersegmental vessel; CA, caudal
artery; CV, caudal vein; CVP, caudal vein plexus. Scale bars, 100 μm (ﬁrst and fourth columns) and 50 μm (ﬁfth column). (B) The numbers of ECs in the CV/ CVP, CA and ISV/
DLAV within the ﬁve ISVs, as observed in A, were counted and shown as means7s.d. (DMSO [n¼10], HU/APH [n¼12]). nnpo0.01, nnnpo0.001. n.s., no signiﬁcance.
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Fig. 6. Cell-cycle progression of ECs during formation of hindbrain vasculature. (A) 3D-rendered confocal images of the hindbrain vasculature in Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-
mC) embryos at 28 hpf. Left, mVenus image; right, the merged image of mVenus (green) and mCherry. All confocal images in this ﬁgure are dorsal views and displayed as
anterior to the top. (B, C) 3D-rendered confocal ﬂuorescence image of the hindbrain vasculature in Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos at 28.5 hpf (B) or 34 hpf (C) and
the corresponding subsequent time-lapse images at the elapsed time (h:min) indicated at the bottom of the upper panel. Upper, mVenus image; lower, the merged image of
mVenus (green) and mCherry. Arrowheads indicate mVenus-positive ECs that sprout from the primordial hindbrain channels (PHBCs) (B) and the ECs that caudally migrate
to form the basilar artery (BA) (C). (D) Confocal ﬂuorescence image of the hindbrain vasculature in 36 hpf Tg(ﬂi1:Myr-mC);( ﬂk1:NLS-Eos) embryos treated from 27 hpf with
DMSO (left) or HU/APH (right). mCherry and the merged images of mCherry (red) and Eos (green) are shown as indicated at the top. Arrowheads indicate defective formation
of the BA. (E) Confocal ﬂuorescence images of the hindbrain vasculature in Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos at 39 hpf and the corresponding subsequent time-lapse
images at the elapsed time (h:min) indicated at the bottom of the upper panel are shown, as in B. Arrowheads indicate mVenus-positive ECs that sprout from PHBCs to form
the CtAs. (F) Confocal ﬂuorescence images of the hindbrain vasculature in 48 hpf Tg(ﬂi1:Myr-mC);( ﬂk1:NLS-Eos) embryos treated from 34 hpf with DMSO (left) or HU/APH
(right) are shown, as in D. Asterisks and arrowheads indicate CtAs and ECs failing to sprout from PHBCs to form the CtAs, respectively. PHBC, primordial hindbrain channels;
LDA, lateral dorsal aorta; BA, basilar artery; CtA, central artery. Scale bars, 100 μm (A–F).
S. Fukuhara et al. / Developmental Biology 393 (2014) 10–23 19
treated with DMSO or HU/APH (Fig. 5A). These ﬁndings show that
EC proliferation is not essential for the formation of the basic
framework structures of caudal vessels. However, the numbers of
ECs in the CA, CV and CVP were signiﬁcantly decreased by HU/APH
treatment (Fig. 5B). Consistently, the distance from the most dorsal
wall of the CA to the most ventral wall of the CV was shorter in the
HU/APH-treated than in the DMSO-treated embryos (Fig. 5A).
Therefore, these results suggest that EC proliferation may be
required for full functional maturation of the caudal vasculature.
Cell-cycle progression of ECs during formation of hindbrain
vasculature
The cranial vasculature is essential for maintaining the central
nervous system, since it delivers oxygen and nutrients to the
entire brain (Rolfe and Brown, 1997). Impairment of cranial vessel
functions leads to cerebrovascular diseases such as stroke and
intracranial hemorrhage (Segura et al., 2009). Thus, we decided to
investigate the cell-cycle progression of ECs during cranial vessel
Fig. 7. Cell-cycle progression of ECs during the late stage of vascular development. (A) 3D-rendered confocal images of the trunk (left) and caudal (right) vasculature in the Tg
(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos at 2, 3 and 4 dpf as indicated at the left. Left, mVenus image; right, the merged image of mVenus (green) and mCherry (red). Scale
bars, 100 μm. (B) The numbers of mVenus-positive ECs in the trunk and caudal vasculature at 2, 3 and 4 dpf, as observed in A, were counted and shown as means7s.d. (2 dpf
[n¼16], 3 dpf [n¼14], 4 dpf [n¼13]). (C) The numbers of mVenus-positive ECs in the DLAV, CA, arterial ISV (aISV), CV/CVP and venous ISV (vISV) of the caudal vasculature at
2 and 3 dpf were quantiﬁed, and then expressed as percentages of the total number (2 dpf [n¼97], 3 dpf [n¼28]).
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formation. We focused on development of the hindbrain vascu-
lature which is comprised mainly of two primordial hindbrain
channels (PHBCs), the midline basilar artery (BA) and several
central arteries (CtAs), since this has been analyzed in detail in
studies focusing on how the hindbrain vasculature is formed, how
ECs assemble, and how EC patterns are involved in vessel forma-
tion (Fujita et al., 2011; Isogai et al., 2001; Ulrich et al., 2011).
Brieﬂy, at the beginning of hindbrain vascular development, a pair
of PHBCs forms on both sides of the ventral-lateral hindbrain by
22–24 hpf. At 28 hpf, ECs sprout from the medial walls of these
PHBCs, migrate medially and form the precursor of the BA, a major
artery in the hindbrain, at the ventral midline. Then, the ECs in the
BA precursor align longitudinally and further migrate caudally to
form the BA. Once assembly of the BA is complete, connections
between the PHBCs and the BAs disappear. In addition to the BA,
ECs sprout from the dorsal surfaces of the PHBCs and form the
CtAs. The CtA sprouts ﬁrst grow dorsally through the hindbrain at
approximately 32 hpf, then turn ventrally and connect to the BA
around 40–48 hpf, making vessel connections between the PHBCs
and the BA.
First, we analyzed the cell-cycle state of ECs during BA forma-
tion by using Tg(ﬂk1:mV-zGem);(ﬂi1:Myr-mC) embryos. At 28 hpf,
the PHBCs contained many S/G2/M phase ECs (Fig. 6A), indicating
active proliferation of these ECs in PHBCs. This observation is
consistent with the previously reported results that the diameter
of PHBCs and the number of ECs in these PHBCs both increase
between 24 and 36 hpf (Ulrich et al., 2011). However, although
some of the ECs that sprouted from PHBCs were found to be in the
S/G2/M phase of the cell-cycle (Fig. 6B), most of the ECs left the
cell cycle after reaching the midline and/or during their subse-
quent caudal migration (Fig. 6C). To investigate the contribution of
EC proliferation to BA formation, we treated the Tg(ﬂi1:Myr-mC);
(ﬂk1:NLS-Eos) embryos with either DMSO or HU/APH for
27–36 hpf. By 36 hpf, the BA had formed at the ventral midline
in DMSO-treated embryos, whereas the HU/APH-treated embryos
exhibited defective BA formation (Fig. 6D). These results suggest
that the ECs in PHBCs proliferate actively to supply the ECs
migrating toward the midline and needed to form the BA,
although EC proliferation does not actually occur during BA
formation.
We next analyzed the cell-cycle progression of ECs during the
formation of CtAs. The PHBCs still contained ECs in the S/G2/M
phase of the cell cycle at 39 hpf. Although a few S/G2/M phase ECs
were observed in the developing CtAs, most of the ECs that
sprouted from PHBCs to form the CtAs were mVenus-negative
(Fig. 6E). These results suggest that CtA formation depends mainly
on migration of ECs derived from PHBCs but also, partly, on EC
proliferation. We further investigated whether EC proliferation is
required for CtA formation by treating the Tg(ﬂi1:Myr-mC);(ﬂk1:
NLS-Eos) embryos with HU/APH for 34–48 hpf. The sprouting of
ECs from PHBCs was severely impaired by HU/APH treatment
(Fig. 6F). Concomitantly, the HU/APH-treated embryos exhibited a
defect in CtA formation (Fig. 6F). These results suggest that the ECs
derived from PHBCs contribute to CtA formation. Thus, prolifera-
tion of ECs sprouted from PHBCs is required not only for BA
formation but also for CtA formation.
Cell-cycle progression of ECs in the late stage of vascular development
Finally, we analyzed the cell-cycle state of ECs in the late stage
of vascular development. At 2 days post-fertilization (dpf), the
trunk vasculature contained several ECs in the S/G2/M phase
(Fig. 7A, B). However, these cells left the cell cycle at 3 and 4 dpf
(Fig. 7A, B). On the other hand, many ECs in the S/G2/M phase of
the cell cycle were present in caudal vessels at 2 dpf (Fig. 7A, B).
However, the number of S/G2/M phase ECs in these caudal vessels
was decreased by approximately 30% at 3 dpf as compared to that
at 2 dpf (Fig. 7B). Furthermore, only a few cells that progressed
through the cell cycle were present in caudal vessels at 4 dpf
(Fig. 7A, B). These results show that more EC proliferation occurs
in caudal than in trunk vessels in the late stage of vascular
development.
We further investigated where ECs proliferate within caudal
vessels in the late stage of vascular development by identifying the
mVenus-positive cells in our Tg(ﬂk1:mV-zGem);(Fli1:Myr-mC)
embryos. At 2 and 3 dpf, most of the ECs in the S/G2/M phase of
the cell cycle were found in venous vessels comprising the CV, CVP
and venous ISV, while only minor populations of ECs were
mVenus-positive in arterial vessels. These ﬁndings suggest that
venous ECs mainly proliferate in the late stage of vascular devel-
opment, whereas arterial ECs become quiescent at this stage.
Discussion
In the present study, by generating the EC-zFucci zebraﬁsh line,
in which zFucci biosensors were speciﬁcally expressed in ECs, we
succeeded in devising a novel imaging system which allows the
cell-cycle progression of ECs to be visualized in living animals. We
assessed whether the EC-zFucci Tg line precisely monitors the cell-
cycle state of ECs by labeling S phase ECs with EdU, by performing
time-lapse imaging analyses and by examining the effects of cell-
cycle inhibitors. Furthermore, we were able to clearly show the
advantage of using the EC-zFucci Tg line by analyzing the cell-cycle
progression of ECs during the development of several vascular
structures including ISVs, caudal vessels and hindbrain vessels,
during both the early and the late stages of vascular development.
The cell-cycle of ECs is ﬁnely controlled during ISV formation.
The development of ISV is a suitable model for studying sprouting
angiogenesis (Blum et al., 2008; Isogai et al., 2003; Lawson and
Weinstein, 2002). Therefore, we analyzed the cell-cycle state of
ECs during ISV formation, and found that ECs progressing through
the cell cycle sprout from the DA and undergo one round of cell
division during dorsal migration to form ISVs. Dll4/Notch signal is
one of the most important negative regulators of sprouting
angiogenesis. Indeed, inhibition of Dll4/Notch signaling leads to
hyper-proliferation of ECs during ISV formation (Leslie et al., 2007;
Siekmann and Lawson, 2007). In addition, cdkn1b, a target of
miR-221, has been shown to inhibit EC proliferation during ISV
formation (Nicoli et al., 2012). Consistently, our analyses using the
EC-zFucci Tg line revealed that knockdown of either dll4 or cdkn1b
promotes cell-cycle progression of ECs in ISVs. Thus, the EC-zFucci
Tg line appears to be a useful system for studying regulation of the
EC cycle in vivo.
Even without EC proliferation in ISVs, ECs migrating from the
DA were able to form the basic framework of ISVs and DLAV,
although proliferation might be required for these vessels to be
fully functional. Unexpectedly, inhibition of EC proliferation with
HU/APH treatment did not inhibit the formation of ISVs and
DLAVs, although the numbers of ECs in these vessels were
signiﬁcantly reduced (Fig. 3J, K). However, although Nicoli et al.
also examined the effect of HU/APH on ISV formation, they
observed a signiﬁcant decrease not only in EC number but also
in ISV length in the HU/APH-treated embryos at 27 hpf (Nicoli
et al., 2012). Since we analyzed the HU/APH-treated embryos at
32 hpf, it is reasonable to speculate that inhibiting EC proliferation
delayed ISV formation, but did not completely prevent it. Consis-
tently, our time-lapse imaging analyses showed no abrogation of
the sprouting of ECs from the DA and subsequent dorsal migration
in response to HU/APH treatment (Supplemental Movie 2). Thus,
these results suggest that EC proliferation and migration may
contribute to ISV and DLAV formation.
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The early stage of caudal vessel formation involves develop-
ment and proliferation of angioblasts. It has been well demon-
strated that angioblasts arise within the lateral plate mesoderm,
and migrate medially to form a vascular cord at the trunk midline,
which gives rise to the DA and PCV (Jin et al., 2005a; Swift and
Weinstein, 2009; Zhong et al., 2001). In this study, we found that
angioblasts emerged in the ventral part of the tail independently
of angioblast formation in the trunk region and contributed to the
formation of caudal vessels. Consistently, mesodermal progenitor
cells reportedly exist in the ventral tail bud and have the ability to
differentiate into both endothelial and somite cell lineages (Martin
and Kimelman, 2012). Collectively, these ﬁndings suggest that the
angioblasts contributing to the development of the trunk and
caudal vasculatures have distinct origins.
Increases in the number of ECs, via cell proliferation, are not
required for the formation of basic framework structures of caudal
vessels, although these increases do appear to be necessary for the
formation of functionally mature caudal vessels. Active prolifera-
tion of angioblasts and ECs at the growing edges of caudal vessels
suggests the involvement of EC proliferation in caudal vessel
formation. However, the basic structures of caudal vessels, includ-
ing ISVs, DLAVs, CA, CV and CVP, could still be established in HU/
APH-treated embryos, despite the numbers of ECs in these caudal
vessels being decreased. Therefore, our observations suggest
angioblast development and migration to be involved in formation
of the basic structures of caudal vessels, whereas EC proliferation
contributes to the generation of fully-functional caudal vessels.
Formation of BA and CtAs in the hindbrain largely depends on
the proliferation of ECs in PHBCs. The ECs sprouting from PHBCs
migrate medially to form the BA and CtAs (Fujita et al., 2011;
Ulrich et al., 2011). Previously, Ulrich et al. investigated the cellular
mechanisms underlying BA and CtA formation, and revealed EC
migration from PHBCs to be the primary mechanism of the
formations of the BA and CtA, while EC proliferation plays a minor
role in these processes (Ulrich et al., 2011). Our imaging analyses
of the EC-zFucci Tg ﬁsh revealed PHBCs to contain a large number
of ECs progressing through the cell cycle, while most of the
sprouting ECs destined to form the BA and CtAs left the cell-
cycle. Furthermore, inhibition of EC division resulted in defective
formation of the BA and CtAs. Therefore, the ECs in PHBCs
proliferate actively to supply the ECs that will ultimately form
the BA and CtAs.
Vessel growth in the late stage of vascular development
depends mainly on the proliferation of venous ECs. In the EC-
zFucci ﬁsh embryos at 2 and 3 dpf, the ECs in the S/G2/M cell-cycle
phases were mainly present in venous vessels of the caudal
vasculature, whereas most of the ECs in the arterial vessels left
the cell cycle, suggesting venous EC proliferation to play a role in
the late stage of vascular development. It is important to ascertain
whether mainly venous ECs also proliferate in the adult vascula-
ture. However, unfortunately, mVenus/mCherry-double negative
ECs were detected in the vasculature of adult EC-zFucci Tg ﬁsh
(data not shown), showing that the cell-cycle state of ECs cannot
be adequately visualized in the adult EC-zFucci Tg ﬁsh. Thus, we
need to improve the EC-zFucci Tg ﬁsh line to analyze the cell-cycle
progression of ECs in adult ﬁsh.
In the present study, we established EC-zFucci Tg zebraﬁsh
lines that allow the spatiotemporal pattern of cell-cycle dynamics
of ECs to be visualized in vivo. To date, we have been able to
visualize ECs undergoing mitosis by utilizing Tg reporter lines in
which the nuclei of ECs were labeled by NLS-tagged ﬂuorescence
proteins. However, these Tg lines do not allow identiﬁcation of the
ECs in each phase of the cell cycle. Therefore, the EC-zFucci Tg line
is more suitable than endothelial-speciﬁc nuclear Tg lines for
analyzing the cell-cycle dynamics of ECs. In addition, the EC-
zFucci Tg line can be used for FACS-based isolation of ECs
according to their cell-cycle stage. Furthermore, the genes impli-
cated in the regulation of EC proliferation during vascular devel-
opment could be identiﬁed by crossing the EC-Fucci ﬁsh lines with
various mutant ﬁshes exhibiting defects in vascular development
or by performing MO-mediated knock-down of candidate genes.
Thus, the EC-Fucci transgenic zebraﬁsh line is anticipated to be a
useful tool for addressing unanswered questions about the sig-
niﬁcance of EC proliferation in vascular development.
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